---
title: "DAYANG BIOTECH: Shareholders increased their holdings to 5.65%, violating relevant regulations, and the Zhejiang Regulatory Bureau issued a warning letter to them"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232372878.md"
description: "DAYANG BIOTECH shareholder Yang Xingli increased his shareholding to 5.65% on February 18, 2025. He violated relevant regulations by not halting trading when his shareholding reached 5%, resulting in a warning letter issued by the Zhejiang Regulatory Bureau, which will be recorded in his integrity file. This matter does not affect the normal operation of the company"
datetime: "2025-03-19T08:15:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232372878.md)
  - [en](https://longbridge.com/en/news/232372878.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232372878.md)
generator: "portal-rs"
---

# DAYANG BIOTECH: Shareholders increased their holdings to 5.65%, violating relevant regulations, and the Zhejiang Regulatory Bureau issued a warning letter to them

DAYANG BIOTECH announced that the company's shareholder Yang Xingli increased his shareholding by 800,000 shares through centralized bidding on February 18, 2025. After the increase, his shareholding rose from 3.95 million shares to 4.75 million shares, accounting for an increase in the total shareholding ratio from 4.7% to 5.65%. Due to failing to halt trading when the shareholding ratio reached 5%, he violated relevant regulations of the "Measures for the Administration of Acquisitions of Listed Companies." The Zhejiang Regulatory Bureau has taken supervisory measures by issuing a warning letter and recording it in the integrity file of the securities and futures market. This matter does not involve other shareholders of the company and will not affect the normal operation of the company

### Related Stocks

- [003017.CN](https://longbridge.com/en/quote/003017.CN.md)

## Related News & Research

- [Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2](https://longbridge.com/en/news/298452346.md)
- [WellCare of Kentucky recognizes 2026 Community Health Champions](https://longbridge.com/en/news/298628612.md)
- [Matica Biotechnology and Bondwell Technologies Collaborate to Advance Texas Biotech Innovation](https://longbridge.com/en/news/298444718.md)
- [National Franchise T.A.C.T. Celebrates Franchisee Feature in Esquire Magazine Highlighting Industry Excellence](https://longbridge.com/en/news/298459621.md)
- [CraniUS Therapeutics Receives FDA 510(k) Clearance for the CraniUS® Plate, a Patient-Specific Cranial Implant](https://longbridge.com/en/news/298452362.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**